Mylab launches combined RT-PCR test for Zika, malaria, dengue

Test can differentiate between seven diseases and give results in 2 hrs

RT PCR
Globally, 17 per cent of infectious diseases are spread by vectors and cause about 700,000 deaths annually.
Sohini Das Mumbai
1 min read Last Updated : Jul 15 2022 | 1:48 AM IST
Pune-based Mylab Discovery Solutions, credited with developing India’s first indigenous Sars-CoV-2 RT-PCR and the first rapid-antigen test home kit, has launched the country’s first combined RT-PCR test kit for monsoon diseases.

The test can detect and differentiate between malaria, Chikungunya, dengue, Zika, Leptospirosis and Salmonellosis bacterial species, and Leishmaniasis parasites.

Mosquito-borne diseases peak during the monsoons. Mylab has developed a fever panel — PathoDetect Extended Monsoon Fever Panel — which is a comprehensive multiplex RT-PCR test kit for all monsoon diseases.

The combined kit can process samples to give results in two hours, and can be used for mass testing as well.

Hasmukh Rawal, founder and managing director of Mylab Discovery Solutions, said: “The precise diagnosis of many of these diseases remains a significant challenge because of the lack of accurate and reliable diagnostic methods.”

Globally, 17 per cent of infectious diseases are spread by vectors and cause about 700,000 deaths annually.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :ZikaMalariaDengueChikungunyaZika virus vaccineMalaria vaccinedengue in IndiaHealth sectorHealthcare sectorRapid Antigen TestingIndiaPune

Next Story